Transformational M&A Not On Horizon For Haleon Or Bayer

Haleon CEO Brian McNamara and Bayer Consumer Health president Julio Triana independently tell the Barclays Consumer Conference that their respective firms are unlikely to secure any transformational mergers or acquisitions in the medium term. Both companies are prioritizing bolt-on acquisitions for the next few years.

• Source: Shutterstock

Even though the global consumer health market remains highly fragmented two of the largest players say they don’t expect to strike any transformational deals any time soon.

More from Strategy

People On The Move: Appointments At Maxwellia, Reckitt, Barentz

 
• By 

A round-up of the latest European consumer health appointments: Maxwellia adds CFO and board member; Reckitt restructures operations; Barentz names CEO.

People On The Move: Appointments At Boiron, Dr. Theiss, ProBiotix

 
• By 

A round-up of the latest European consumer health industry appointments: Boiron hires former Henkel exec as CEO; Dr. Theiss Naturwaren names managing director; ProBiotix Health adds scientific expertise.

People On The Move: Appointments at CHP Australia, Opella, Ascendis

 
• By 

Round-up of the latest people moves: CHP Australia names new chief exec; Opella appoints Vietnam head; Ascendis makes permanent CFO appointment.

People On The Move: Appointments At Haleon, Stada, Aker BioMarine

 
• By 

A round-up of the latest European consumer health industry appointments: Haleon adds to board; Stada names investor relations head; Aker BioMarine hires marketing expert.

More from Business

USANA’s $205M Majority Stake In Hiya Brings ‘Kidsperience’ And Direct-To-Consumer Sales

 

Hiya has more than 200,000 customers in the direct-to-consumer channel, all using subscriptions ordered on the brand’s website, and plans to expand into online marketplaces and retail chains. The startup “offers a compelling subscription model with attractive margins, profitability, and strong cash flow generation,” says USANA CEO Jim Brown.

People On The Move: Appointments At Boiron, Dr. Theiss, ProBiotix

 
• By 

A round-up of the latest European consumer health industry appointments: Boiron hires former Henkel exec as CEO; Dr. Theiss Naturwaren names managing director; ProBiotix Health adds scientific expertise.

Whey Protein Production Needs Ultraviolet Light Option For Eliminating Contaminants – US Petition

 

Petition by Leprino Nutrition could help manufacturers trim production spending as costs increase throughout the supply chain leading to higher product prices even as the global whey protein ingredient market reached nearly $9bn in 2023 and is projected to reach nearly $23bn in 2032.